Nano Dimension calls out Stratasys for having to be 'reminded' of legal requirement to have board members voted on individually
Nano Dimension Ltd. (NNDM) called out 3D printer maker Stratasys Ltd. (SSYS), for having to be reminded about its legal requirement to allow shareholders to vote for board members individually, rather than for an entire slate proposed by the company. As it result, Stratasys shareholders can now vote for the seven board candidates proposed by Nano Dimension individually at Stratasys' annual meeting on Aug. 8. "While Stratasys claims its candidates are highly qualified and independent, it is clear that they are in fact an entrenched group with an average tenure on the Stratasys Board of 12-15 years, over which time they have overseen significant value destruction," Nano Dimension said in a statement. The company added that Stratasys shareholders had to replace 5/8s of their board to receive Nano Dimension's $25-per-share cash tender offer, which represents a 26.2% premium to current prices. Stratasys, which currently owns 14.1% of Stratasys' outstanding shares, had increased its offer last week to buy between 31.9% and 36.9% of the outstanding shares, which Stratasys urged its shareholders to reject. Stratasys said last week that the latest cash-and-stock buyout bid from 3D Systems Corp. (DDD) was likely a "superior proposal" to previously agreed-on bid from Desktop Metal Inc. (DM)
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-25-23 1104ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth